Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial

Patricia R. M. Rocco, Pedro L. Silva, Fernanda F. Cruz, Marco Antonio C. M. Junior, Paulo F. G. M. M. Tierno, Marcos A. Moura, Luís Frederico G. De Oliveira, Cristiano C. Lima, Ezequiel A. Dos Santos, Walter F. Junior, Ana Paula S. M. Fernandes, Kleber G. Franchini, Erick Magri, Nara F. de Moraes, José Mário J. Gonçalves, Melanie N. Carbonieri, Ivonise S. Dos Santos, Natália F. Paes, Paula V. M. Maciel, Raissa P. Rocha, Alex F. de Carvalho, Pedro Augusto Alves, José Luiz P. Modena, Artur T. Cordeiro, Daniela B. B. Trivella, Rafael E. Marques, Ronir R. Luiz, Paolo Pelosi, Jose Roberto Lapa e Silva on behalf of the SARITA-2 investigators
doi: https://doi.org/10.1101/2020.10.21.20217208

Data Availability

The investigators plan on turning all individual participant data (IPD) available after the publication of the manuscript, with cautious of not sharing confidential data.

Back to top
Posted October 23, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Early use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial
Patricia R. M. Rocco, Pedro L. Silva, Fernanda F. Cruz, Marco Antonio C. M. Junior, Paulo F. G. M. M. Tierno, Marcos A. Moura, Luís Frederico G. De Oliveira, Cristiano C. Lima, Ezequiel A. Dos Santos, Walter F. Junior, Ana Paula S. M. Fernandes, Kleber G. Franchini, Erick Magri, Nara F. de Moraes, José Mário J. Gonçalves, Melanie N. Carbonieri, Ivonise S. Dos Santos, Natália F. Paes, Paula V. M. Maciel, Raissa P. Rocha, Alex F. de Carvalho, Pedro Augusto Alves, José Luiz P. Modena, Artur T. Cordeiro, Daniela B. B. Trivella, Rafael E. Marques, Ronir R. Luiz, Paolo Pelosi, Jose Roberto Lapa e Silva
medRxiv 2020.10.21.20217208; doi: https://doi.org/10.1101/2020.10.21.20217208
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area